Whereas PD1 antibody-targeted monotherapy moderately inhibited the growth of tumors from wild-type YTH16 (m) xenografts, anti-PD1 antibody monotherapy caused a more pronounced suppressive effect on tumor growth in tumors from YTH16 (m) cells with SOX13 knockout. This evidence concerns the gene SOX13 and neoplasm.